Clinical Trials in Michigan

Showing 8521-8540 of 16,154 trials

Effect of Early Administration of TXA in Adult Hip Fractures

NCT05047133

This is a prospective clinical study designed to assess blood loss in intracapsular and extracapsular hip fractures undergoing operative fixation at a Level II trauma center. It is well established in the orthopedic literature that tranexamic acid (TXA) decreases blood loss and need for postoperative blood transfusion in hip fracture patients as well as total joint arthroplasty patients. A typical dosing pattern, and the dosing pattern employed at our institution, is 1 gram IV infused prior to incision followed by 1 gram IV infused at the time of wound closure.

Postoperative Blood Loss

Ascension Health170 participantsStarted Sep 2021

Grand Blanc, Michigan, United States

COMPLETEDPhase 283 miles

An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly

NCT00171730

Acromegaly is a rare, serious condition characterized by chronic hypersecretion of growth hormone (GH), generally caused by a GH-secreting pituitary adenoma. The study assessed the long-term safety and efficacy of pasireotide in participants with acromegaly.

Acromegaly

Novartis Pharmaceuticals30 participantsStarted Aug 2004

Los Angeles, California, United States • Ann Arbor, Michigan, United States • New York, New York, United States +7 more locations

COMPLETEDPhase 383 miles

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

NCT02435992

The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC).

Ulcerative Colitis

Celgene1,012 participantsStarted Jun 2015

Sun City, Arizona, United States • Tucson, Arizona, United States • North Little Rock, Arkansas, United States +369 more locations

Effect of Early Administration of TXA in Adult Hip Fractures

An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

Find Trials by Condition in Michigan

Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants

Delphinus SoftVue Prospective Case Collection - ARM 1

Real World Evidence of the Efficacy and Safety of FOQUEST

221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

Pain Control Following Sinus Surgery

A Multicenter Prospective Study of Quality of Life in Adult Scoliosis

Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137)

aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation

Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study

A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation

Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

GARNET™ Filter (GARNET Device) IDE Used in Chronic Hemodialysis Patients With a Bloodstream Infection

Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)

A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma

A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer